Skip to content

Russian Central Bank: High Interest Rates Are a Needed 'Prescription Drug'

Sounding for all the world like the IMF bureaucrats meeting in Washington, D.C. on April 24-25, Bank of Russia Governor Elvira Nabiullina said at a Moscow press conference after a meeting of the Bank’s Board that they would keep the key rate at 21%, arguing that high interest rates are a “prescription drug” against inflation “that was and is successfully used by central banks in many countries.” According to a report in TASS, Nabiullina also warned that “any delay or insufficient ‘dosage’ may only make the situation worse … [and that] it will be needed to keep stringent monetary conditions for a long period of time.”

Patting herself on the back, Nabiullina asserted that central bank autonomy is “an indicator of maturity of the economic policy” in the country.

This post is for paying subscribers only

Subscribe

Already have an account? Sign In